
| 3,4-Dihydro-7-hydroxy-2(1H)-quinolinone Basic information |
| Product Name: | 3,4-Dihydro-7-hydroxy-2(1H)-quinolinone |
| Synonyms: | AURORA KA-4813;(1H)-7-HYDROXY-3,4-DIHYDRO-2-QUINOLINONE;7-HYDROXY-1,2,3,4-TETRAHYDRO-2-QUINOLINONE;7-HYDROXY-1,2,3,4-TETRAHYDROQUINOLIN-2-ONE;7-HYDROXY-1,2,3,4-TETRAHYDROQUINOLINE-2-ONE;7-HYDROXY-3,4-DIHYDRO-1H-QUINOLIN-2-ONE;7-HYDROXY-3,4-DIHYDRO-2(1H)-QUINOLINONE;7-HYDROXY-3,4-DIHYDRO-2-OXO-(1H)-QUINOLINE |
| CAS: | 22246-18-0 |
| MF: | C9H9NO2 |
| MW: | 163.17 |
| EINECS: | |
| Product Categories: | Quinolines, Quinazolines and derivatives;Quinoline derivatives;INTERMEDIATESOFARIPIPRAZOLE;Aromatics Compounds;Intermediates of Aripiprazole;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Heterocycles |
| Mol File: | 22246-18-0.mol |
![]() | |
| 3,4-Dihydro-7-hydroxy-2(1H)-quinolinone Chemical Properties |
| mp | 233-237 °C |
| CAS DataBase Reference | 22246-18-0(CAS DataBase Reference) |
| Safety Information |
| Hazard Codes | Xn,Xi |
| Risk Statements | 22-43 |
| Safety Statements | 36/37 |
| MSDS Information |
| Provider | Language |
|---|---|
| SigmaAldrich | English |
| 3,4-Dihydro-7-hydroxy-2(1H)-quinolinone Usage And Synthesis |
| Chemical Properties | Pale Yellow Powder |
| Usage | An antitumor agent. Hydroxyindole analog inhibitor tyrosinase melanoma. |